ReviewBiochemical pharmacology2010
Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail.
Gajanan S Inamdar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
107 papers cite itlatest 60 shown
this papertrialcites it